Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 5NET 3Thoracic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Brain Neoplasms 104Glioblastoma 99Glioma 80Neuroblastoma 32Central Nervous System Neoplasms 28Neoplasms 24Medulloblastoma 24Astrocytoma 24Sarcoma 22Meningioma 22Ependymoma 22Neurofibromatosis 1 20Melanoma 17Rhabdoid Tumor 16Breast Neoplasms 16Wilms Tumor 14Neurofibroma, Plexiform 14Rhabdomyosarcoma 13Osteosarcoma 13Hepatoblastoma 13Thyroid Neoplasms 12Sarcoma, Ewing 12Gliosarcoma 12Carcinoma, Non-Small-Cell Lung 12Diffuse Intrinsic Pontine Glioma 11Recurrence 10Pheochromocytoma 10Pancreatic Neoplasms 10Ovarian Neoplasms 10Lymphoma, Non-Hodgkin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoid Tumor × CNS × 30 days × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡